Stock Track | 10x Genomics Soars 9.94% in Pre-Market on Multiple Analyst Target Price Raises

Stock Track
02/13

10x Genomics Inc (TXG) saw its stock price surge 9.94% during pre-market trading, indicating strong investor interest ahead of the regular session.

The significant price movement follows a series of positive analyst actions, with multiple financial institutions raising their target prices for the genomics company. Deutsche Bank increased its target to $17 from $16, JP Morgan raised to $17 from $15, Jefferies lifted to $21 from $17, Stifel boosted to $20 from $15, and TD Cowen moved to $19 from $18.

These coordinated analyst upgrades suggest growing optimism about 10x Genomics' business prospects and future performance, driving increased buying activity in the pre-market session.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10